Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Down – Time to Sell?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped down before the market opened on Tuesday . The stock had previously closed at $15.40, but opened at $14.56. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $14.80, with a volume of 469 shares traded.

Analyst Ratings Changes

Several research analysts have commented on TLX shares. UBS Group began coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They set a “buy” rating and a $21.00 target price for the company. William Blair upgraded shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Up 3.2 %

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.